CEO Today - Healthcare Awards 2023

CEO Today Healthcare Awards 2023 - 16 - - AUSTRALIA - We have navigated through these challenges by aligning resources to meet market needs and introducing products that meet customer demand. For example, medi Vision, our contactless measuring device, has been in development since 2018. It was introduced during the pandemic and met the need for social distancing while providing an essential service for patients. We have forged strategic partnerships with retailers and distributors that align with our values and behaviours. Finally, we have doubled down on maintaining a customer-centric approach. Looking ahead, we see immense opportunities in continuing to develop and introduce products that promote patient self-management and care. We also continue to drive education and workshops to clinicians across our product portfolio – by delivering market-leading education, we strive to enhance our customer and patient experience in their use of our products. How does medi Australia prioritise a patient-centric approach, and how has this impacted patient outcomes and satisfaction? At medi, the patient is at the heart of our operations. We strive to have everyone say, “medi. I feel better” following their interaction with medi Australia. We actively seek and incorporate feedback, ensuring our products align with patients’ needs and preferences – in effect, we are a catalyst between the medical industry and specialist retailers/ therapists. The range of medical services includes medical compression stockings, adaptive compression aids, supports, orthoses, thrombosis prophylaxis stockings, compression garments and orthopaedic shoe insoles. This approach has significantly improved patient outcomes and satisfaction, as patients feel heard and valued throughout their healthcare journey. Having dedicated over a decade to the healthcare sector, could you share your observations on the transformations that have occurred, mainly focusing on the advancements and enhancements made to medi products? The past decade has seen a significant rise in the role of technology in the patient treatment pathway. As a global company, medi strives to be a world leader in the sectors in which we operate. We drive the implementation of these patient-orientated solutions in the Australian market. We recently partnered with our American colleagues and two worldleading universities to research the early detection and treatment of lymphoedema following breast cancer. Implementing this practice-altering research in an early intervention model of care can change patients’ lives. Globally, medi has pioneered advancements in garment measuring technology and with “medi vision”, we are the only company that offers a mobile, contactless measuring modality for compression garments. medi has continually been at the forefront of these initiatives, constantly enhancing our products to ensure optimal effectiveness and patient comfort. In orthopaedics, medi regularly brings together interdisciplinary groups of physicians to discuss the most pressing issues in treatment of patients. Most recently, medi hosted our second annual conference on ACL injuries in Female Football (soccer) players. In doing this, medi can ensure we continue to deliver research-based best practices in the solutions we provide for these patient groups. More broadly, how have you seen the healthcare industry evolve in Australia, and what role has medi played in driving this change? The healthcare industry in Australia has seen a shift towards a more patient-centric approach, with a greater emphasis on personalised care and holistic well-being. medi has played an instrumental role in assisting clinicians in driving this change by developing innovative solutions that address specific healthcare needs. In the past three years, we have introduced multiple new products to the Australian market. Our dedication to patient-focused care, technological advancements, and continuous improvement has contributed to the overall enhancement of healthcare experiences and outcomes in the country. Can you share some of the critical challenges medi Australia has faced and how you have navigated through them? Additionally, what opportunities do you foresee in the Australian healthcare sector? Like all businesses, we have encountered challenges in the past few years, from COVID-19 to price increases (inflation) and market competition. “As a global company, medi strives to be a world leader in the sectors in which we operate.”

RkJQdWJsaXNoZXIy Mjk3Mzkz